Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer

NCT03214991 is registered in ClinicalTrials.gov with Ji Kon Ryu as lead sponsor.

NCT NCT03214991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03214991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer
Lead sponsor
Ji Kon Ryu
Phase
Observational
Overall status
Unknown status
Start date
May 12, 2017
Completion date
March 31, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer